Objective: In this study, the main objective was to evaluate the association of markers of obesity with the inflammatory markers in pre-diabetes and diabetes.
INTRODUCTION
Since the past few decades, an increasing trend in the incidence of obesity has been observed. Before Hippocrates who categorized obesity as a medical disorder, obesity was merely regarded as a cosmetic problem. Later, researches documented obesity as the causative agent to various abnormalities such as dyslipidemia, hypertension, diabetes, metabolic syndrome, and cardiovascular diseases (CVDs) [1] . Diabetes mellitus, a metabolic disorder induced by insulin resistance [2] , is one of the serious outcomes of obesity. According to different animal studies, brown adipose tissue is chiefly involved in glucose and energy homeostasis [3] , while white adipose tissue especially visceral type is the source of inflammatory mediators such as adiponectin, tumor necrosis factor-α, interleukin-6 (IL-6), and leptin [4] .
The previous studies have reported increased expression of proinflammatory cytokines in obesity, thereby suggesting the link between inflammation, obesity, and its associated complications [5] . As individual progresses to obesity, the adipocytes become hypertrophic and hyperplastic with a consequent reduction in blood supply leading to hypoxia that incites infiltration of macrophages into and necrosis of adipocytes causing the production of pro-inflammatory molecules in the excess amount [6] . Alterations in adipocyte physiology unhinge its anti-inflammatory and pro-inflammatory secretory balance, thereby favoring dysglycemia which on the long-term leads to diabetes and cardiovascular complications [7] .
Diabetes development follows a dormant pre-diabetic phase which though is a hyperglycemic state is characterized by glycemia above and below the range of normal and diabetic state [8] . Pre-diabetes is also associated with overweight, obesity, and inflammatory phenomenon. Pre-diabetic subjects are not only at a high risk of future diabetes but also are at the high propensity of cardiovascular complications mediated by obesity and inflammation. Thus, regular monitoring of adipokines may be useful in selecting these mediators as therapeutic targets to decrease obesity incidences and its associated risks in hyperglycemic patients. Thus, this study was put forth to evaluate the association of obesity indices (body mass index [BMI], waist circumference [WC], and waist-hip ratio [WHR]) with inflammatory mediators in pre-diabetic and diabetic subjects. Furthermore, there is the paucity of studies correlating the mediators of obesity with inflammatory mediators in Indian population.
METHODS
This present study was an observational case-control study with 100 of each pre-diabetic and diabetic subjects. A total of 100 healthy volunteers were recruited as a control group.
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(for glucose estimation), plain vial (for estimation of inflammatory molecules such as adiponectin, uric acid, CRP and IL-6), and EDTA vial (for fibrinogen and glycated hemoglobin estimation). The samples were centrifuged and the serum or plasma collected was kept at −80°C until the day of analysis.
Anthropometric measurements
The anthropometric variables included in the present study were BMI, WHR, and WC. For the estimation of BMI, the height (in cm) was measured using stadiometer with the participants standing barefoot. Weight (in kg) was measured using a balanced weight measurement scale. Then, the BMI was calculated as:
BMI=
Weight (kg) Height (m ) 2 Based on BMI value, the participants were grouped as:
• Normal→18.5-24.9 • Overweight→25-29.9 • Obese→≥30.
The WC and hip circumference were measured using a measuring tape.
• WC: Measured midway between last rib and iliac crest • Hip circumference: Measured around the widest part of the hip.
The WHR was calculated as:
WHR= Waist circumference(cm) Hip circumference(cm)
Based on WHR, the participants were categorized into groups, namely participants with WHR <0.9 and WHR >0.9 (as per WHO criteria). Similarly, based on WC, the participants were group as those with WC ≤90 and those with WC >90 (as per International Diabetes Federation cutoff points for South Asians) [1] .
Assay of biochemical parameters
Biochemical analytes such as glucose, HbA1c (glycated hemoglobin), uric acid, CRP, IL-6, fibrinogen, and adiponectin were estimated by commercially available standard kits.
• Fasting blood glucose (FBG)→GODPOD (glucose oxidase-peroxidase) method • HbA1c→Ion exchange resin method • Uric acid→Uricase method • Fibrinogen and CRP→Immunoturbidimetric method • IL-6 and adiponectin→Enzyme-linked immunoadsorbent assay.
Statistical analysis
The values were represented in terms of mean±standard deviation. The comparative analysis was done by Student's t-test. Pearson's correlation coefficient was calculated to determine the association between the variables. p<0.05 indicated statistical significance.
RESULTS
In this study, 300 participants were enrolled who were categorized into three groups involving 100 each of control group, pre-diabetic group, and diabetic group. The incidence of obesity (general and abdominal) in each group was determined ( Fig. 1 ). General obesity was indicated in terms of BMI ≥25 while abdominal obesity was represented in terms of WHR ≥0.9 and WC >90 cm. The prevalence of obesity increased from control-prediabetic-diabetic categories (i.e., 23%, 30%, and 43%; 40%, 43%, and 52%; and 20%, 26%, and 31%, respectively).
In Table 2 , demographic variables (age, BMI, WHR, and WC) and biochemical variables (FBG, HbA1c, uric acid, CRP, fibrinogen, IL-6, and adiponectin) were compared between the study groups. Significantly, high values of demographic variables were found as the groups progressed from normoglycemia to hyperglycemia. There was also a significant elevation in FBG, HbA1c, inflammatory variables (uric acid, CRP, fibrinogen, and IL-6) and a significant decrease in an anti-inflammatory variable (adiponectin) when the comparison was made between control/pre-diabetes and control/diabetes groups. The mean values of serum adiponectin were 8.7±2.6 μg/mL, 8.09±1.94 μg/ mL, and 6.74±1.89 μg/mL for control, pre-diabetes, and diabetes, respectively. Likewise, the mean values of uric acid, CRP, fibrinogen, and IL-6 were 4.49±0.75 mg/dL, 4.71±1.04 mg/ dL, and 6.33±2.6 mg/ dL; 2.77±1.18 mg/mL, 4.29±1.39 mg/mL, and 5.12±1.68 mg/mL; 3.32±0.58 mg/mL, 4.49±0.55 mg/mL, and 3.76±0.62 mg/mL; and 4.41±1.87 pg/mL, 5.93±1.91 pg/mL, and 7.65±2.26 pg/mL, respectively, for control, pre-diabetic, and diabetic groups.
The obesity indices were correlated with inflammatory variables as shown in Tables 3 and 4 . Among pre-diabetic patients, a significant inverse association was established between adiponectin and WHR (r=−0.23, p<0.05) only while the correlations of rest variables were insignificant (p>0.05). Among the diabetic patients, BMI correlated significantly with CRP (r=0.4, p<0.05), IL-6 (r=0.34, p<0.5), and adiponectin (r=−0.49, p<0.05) while WC was correlated with all other inflammatory variables except uric acid (r=0.1, p>0.05 for uric acid; r=0.33, p<0.05 for CRP; r=0.25, p<0.05 for IL-6; r=0.22,p<0.05 for fibrinogen; and r=−0.31,p<0.05 for adiponectin) but the correlation of WHR with these markers was insignificant (p>0.05).
The levels of inflammatory variables were also evaluated at different degrees of BMI, WHR, and WC. The pattern observed was a decrease in the level of adiponectin and an increase in the level of uric acid, CRP, fibrinogen, and IL-6 with the increase in the degree of obesity indices (Figs. 2-7) .
DISCUSSION
Changes in living style due to urbanization have arisen a major global concern called obesity that leads to several metabolic complications. Obesity chiefly measured by BMI is a well-characterized risk factor of diabetes [9] . Increased BMI is suggestive of general or overall obesity while visceral or abdominal obesity is suggestive of increased WHR and WC. Now, it is widely accepted that visceral obesity plays a pivotal role in mediating insulin resistance that finally culminates in diabetes mellitus [10] . Increased obesity also predisposes individuals to future risk of CVDs and the risk is further amplified in pre-diabetic and diabetic patients.
Obesity is associated with low-grade inflammation due to the expansion of adipose tissue chiefly of visceral origin. The presence of abnormal adipocytes at ectopic sites affects overall body metabolism. Further, the infiltration of macrophages in adipose tissues stimulates hepatic insulin resistance and chronic inflammation [11] . Several studies have confirmed the fact that low-grade inflammation for a prolonged duration with an increase in circulating inflammatory markers will facilitate the development of pre-diabetes and diabetes. It is also a wellknown fact that most of the pre-diabetic individuals finally progress to diabetes; however, the individuals who are overweight or obese with sedentary life are more prone to progress. Since the inflammatory milieu is mechanistically involved in this vicious cycle, in the present study an effort was made to evaluate the association of obesity indices (BMI, WHR, and WC) with inflammatory mediators in pre-diabetes and diabetes.
In this study, an increased prevalence of obesity (general and abdominal) was observed in the pre-diabetic group and diabetic group compared to the control group. About 30% of pre-diabetic and 43% of diabetic patients exhibited general obesity, while 43% and 26% of pre-diabetic patients, and 52% and 31% of diabetic patients showed abdominal obesity in terms of WHR and WC, respectively. The previous studies also reported higher incidences of obesity in hyperglycemic patients. Verma et al. [12] reported 34.7% of pre-diabetic patients to be overweight. Similarly study of Ahmad et al. [13] and Malini et al. [14] demonstrated 36.82% and 50% of diabetic patients, respectively, to be overweight. The mean values of BMI and WHR were significantly high in patient groups compared to the control group, while such difference was nor found in the case of WC. In several studies, WC is considered a strong predictor of diabetes in comparison to BMI [15] . However, in studies of Oda and Kawai [16] and Janghorbani and Amini [17] , significant differences were not observed in the mean values of BMI which was in contrast to this study, and WC which was similar to this study.
This study also evaluated the levels of inflammatory mediators and their association with obesity indices in patient groups (pre-diabetes and diabetes). Adiponectin (anti-inflammatory adipokine) decreased and pro-inflammatory molecules such as CRP, IL-6, uric, and fibrinogen increased significantly compared to control groups. Our results were in accordance with the previous studies such as that of Upadhyaya et al. [18] , Pradhan et al. [19] , Kafle and Shrestha [20] , and Srikanth et al. [21] . In the case of pre-diabetic subjects, only WHR was correlated 
Fig. 3: Effect of body mass index on the level of inflammatory markers in diabetes
linearly with uric acid and inversely with adiponectin. Both associations were statistically significant. In the case of diabetic subjects, inflammatory mediators correlated significantly with BMI and WC but not with WHR. The previous studies have also reported the significant association of obesity indices, especially BMI with the inflammatory mediators. Kong et al. [22] and Uslu et al. [23] demonstrated an inverse association of adiponectin with BMI in diabetic patients. Likewise, Sachan et al. [24] and Shantaram and Nayak [25] suggested a positive association of CRP with obesity in diabetes. IL-6 was correlated linearly with BMI and WC in the study of Kluppelholz et al. [26] , Malenica et al. [27] , and Agrawal et al. [28] . Similarly, Harsoor et al. [29] and Kafle and Shrestha [20] showed a positive association of fibrinogen with BMI while Urbanavicius et al. [30] depicted positive correlation of uric acid with BMI and WHR.
Regarding the mechanistic phenomenon, it has been hypothesized that increased adiposity mediates the upregulation of pro-inflammatory genes through activation of C-Jun-N terminal kinase and nuclear factor kappa beta, a central regulator of inflammation. These activated genes cause the release of excess amount of cytokines, thereby exacerbating inflammatory responses and leading to insulin resistance which is the major contributor to pre-diabetes and diabetes [31] .
CONCLUSION
The result of our study indicated the significant association of inflammatory mediators with markers of obesity like BMI, WHR, and WC in pre-diabetes and diabetes. Both obesity and inflammation are important risk factors of diabetes and CVDs in pre-diabetic and diabetic patients. This study though simple and conducted on a small sample size can explicate the adverse outcomes of obesity in hyperglycemic patients. Further, this study could be useful in identifying the pre-diabetic and diabetic individuals at high risk so that early intervention by a change in lifestyle, weight loss, and improved dietary habit along with the treatment may prevent the associated complications. Since pre-diabetes is the final gateway to prevent the progression to diabetes and future complications timely management of obesity in the pre-diabetic state may fruitful. However, further elaborated studies with larger sample size are also suggested. Researches on therapeutic approaches which can decrease inflammatory mediators and increase anti-inflammatory mediators are encouraged so that the incidence of obesity-induced inflammatory complications may be alleviated in hyperglycemic patients. AdiponecƟn IL-6 CRP U ric acid Fibrinogen <0.9
≥0.9
Fig. 5: Effect of waist-hip ratio on the level of inflammatory markers in diabetes

